Objective To systematically evaluate the effectiveness and safety of China-made omeprazole in treating acute non-variceal upper gastrointestinal bleeding. Methods Such databases as PubMed, MEDLINE, Springer, The Cochrane Library, CNKI, VIP, CBM and WanFang data were searched to collect the randomized controlled trials (RCTs) about China-made omeprazole in treating acute non-variceal upper gastrointestinal bleeding, and the references of included studies were also retrieved. The retrieval time was from inception to December 2012. Two reviewers independently screened the literature according to the inclusion and exclusion criteria, extracted the data, and assessed the quality, and then the meta-analysis was conducted by using RevMan 5.1 software. Results A total of 11 RCTs were included. Among all 1 075 patients, 544 were in the treatment group, while the other 531 were in the control group. The results of meta-analysis showed that, there were no significant differences in the total effective rate (OR=0.68, 95%CI 0.35 to 1.33, P=0.26) and safety (RR=1.33, 95%CI 0.45 to 3.91, P=0.96) between the China-made omeprazole and imported omeprazole. Conclusion China-made omeprazole is effective and safe in treating acute non-variceal upper gastrointestinal bleeding in comparison with the imported omeprazole.
ObjectiveTo evaluate the performance, including stability and cutting efficiency, of a domestically produced S model dual-blade, dual-port vitrectomy probe during vitrectomy surgery. MethodsA prospective, randomized controlled, non inferiority, multicenter clinical trial study. 120 patients who underwent PPV treatment at Xiamen Eye Center, Department of Ophthalmology of Peking University People’s Hospital, and Department of Ophthalmology, Peking University International Hospital in August 2025 were included in the study. According to the cutting frequency and instrument source, they are divided into 4 groups: 10 k cpm domestic S-type vitrectomy probe group, imported A-type vitrectomy probe group, and 20 k cpm S-type vitrectomy probe group and A-type vitrectomy probe group, with 30 cases in each group. The S-type vitrectomy probe adopts a double-edged dual air path design at frequencies of 10 and 20 k cpm; The A-type vitrectomy probe has a single blade design at a frequency of 10 k cpm and a double-edged design at a frequency of 20 k cpm. Compare and observe the differences in cutting efficiency, safety (incidence of iatrogenic retinal tears), and equipment stability (bubble generation, frequency and negative pressure changes, defect detection) between two groups. The comparison between groups was conducted using the chi square test. ResultsDue to missing data from one patient in the 20 k cpm S-type vitrectomy probe group, 119 cases were ultimately included in the statistical analysis. Among them, there were 59 cases in the S-type probe group (30 cases at 10 k cpm and 29 cases at 20 k cpm), and 60 cases in the A-type probe group (30 cases at 10 k cpm and 20 k cpm each). There was no significant difference in age, sex composition ratio, eye type, whether to combine cataract surgery, anesthesia mode, disease classification, proliferative vitreoretinopathy and proliferative membrane grading of proliferative diabetes retinopathy between 10 k cpm, 20 k cpm S-type vitrectomy probe group and A-type vitrectomy probe group (P>0.05). There was no statistically significant difference in cutting efficiency, cutting safety, equipment stability, frequency and negative pressure fluctuation amplitude, and defect detection between the two groups (P>0.05). In terms of bubble generation in equipment stability, the 20 k cpm S-type vitrectomy probe group performed significantly better than the A-type vitrectomy probe group, and the difference was statistically significant (P=0.027). ConclusionThe domestic S-type vitrectomy probe is non-inferior to the imported A-type vitrectomy probe across multiple performance indicators and shows superior anti-bubble performance.